Baseline Vitals Before Dosing
Resting heart rate, blood pressure and temperature are captured first.
- 60–80: Resting HR (bpm, healthy adult)
- 120/80: Resting BP (mmHg, typical)
- 36.5–37.2: Core temp (°C, normal range)
- Low: Strain level (no sympathetic load)
Why a baseline matters
A pre-dose baseline anchors every later comparison point.
Placeholder: baseline recording is a short standard first step.
Onset of Sympathetic Activation
Norepinephrine and serotonin release begin raising heart rate.
- 20–40 min: Onset window (typical oral onset)
- +15–25: HR rise (bpm above baseline)
- +10–20: BP rise (mmHg systolic)
- Moderate: Strain level (rising sympathetic tone)
Early sympathetic signs
Placeholder: early activation raises heart rate gradually.
Placeholder: monitor for early tachycardia and rising BP.
Peak Heart Rate and Blood Pressure Elevation
Peak plasma concentration drives maximum cardiovascular load.
- ~90–120 min: Peak time (post-dose window)
- 120–160: Peak HR (bpm possible)
- 150–190: Peak systolic (mmHg possible)
- High: Strain level (sustained cardiac load)
Peak physiological demand
Placeholder: peak load stresses heart and vasculature together.
Placeholder: this window carries the highest cardiac risk.
Hyperthermia Risk Monitoring
Core temperature can climb sharply with heat and exertion.
- ≥39.5°C: Danger threshold (hyperthermia zone)
- Ambient heat: Contributing factor (crowded, hot venues)
- Physical activity: Contributing factor (prolonged dancing)
- Variable: Risk status (depends on environment)
Environmental amplifiers
Placeholder: heat and exertion amplify temperature rise sharply.
Placeholder: hyperthermia is a leading serious complication risk.
Cooling and Recovery Protocol
Active cooling and rest allow vitals to normalize gradually.
- 3–6 hrs: Recovery window (gradual normalization)
- Passive/active: Cooling method (fans, fluids, rest)
- Gradual: HR normalization (returns toward baseline)
- Declining: Strain level (load tapers off)
Supporting safe recovery
Placeholder: cooling and hydration support gradual vital recovery.
Placeholder: continued monitoring is advised into recovery.